Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - F-star Therapeutics, Inc. | d77314dex322.htm |
| EX-31.1 - EX-31.1 - F-star Therapeutics, Inc. | d77314dex311.htm |
| EX-32.1 - EX-32.1 - F-star Therapeutics, Inc. | d77314dex321.htm |
| EX-31.2 - EX-31.2 - F-star Therapeutics, Inc. | d77314dex312.htm |
| EX-10.11.3 - EX-10.11.3 - F-star Therapeutics, Inc. | d77314dex10113.htm |
| EX-10.11.2 - EX-10.11.2 - F-star Therapeutics, Inc. | d77314dex10112.htm |
| EX-10.9 - EX-10.9 - F-star Therapeutics, Inc. | d77314dex109.htm |
| 10-K - 10-K - F-star Therapeutics, Inc. | d77314d10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-215122 and 333-234436) and in the Registration Statements on Form S-8 (Nos. 333-212047, 333-226508, 333-252396, 333-251033 and 333-243754) of F-star Therapeutics, Inc. of our report dated March 30, 2021 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Cambridge, United Kingdom
March 30, 2021